Written by
Additional Posts
MAP Pharmaceuticals recently completed patient enrollment in the efficacy (effectiveness) part of its initial Phase 3 clinical trial testing the orally inhaled MAP0004, used for acute Migraine attacks.
850 Migraineurs are evaluating the effectiveness and safety of M...
Thanks for the information.
I live in canada. Is this in effect yet or only in the states?
MAP0004 is not available yet anywhere. This drug is still in its clinical trial stage.
Trexmet is available in the US, but I'm not sure about CA. I went to the Treximet site HERE but didn't see anything helpful about it being available in Canada. There are mail order pharmacies you may check into. Have you asked your pharmacist about Treximet?